Literature DB >> 9797555

Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis.

S Wakisaka1, N Suzuki, M Takeno, Y Takeba, H Nagafuchi, N Saito, H Hashimoto, T Tomita, T Ochi, T Sakane.   

Abstract

OBJECTIVE: To elucidate possible roles of several transcription factors in the pathogenesis of rheumatoid arthritis (RA), the transcription factor expression in RA synovial tissue and their contribution to RA synovial cell functions were studied.
METHODS: Single cell suspension of dissociated synovial tissue was cultured to induce in vitro tissue outgrowth of RA synovial cells. Transcription factors were immunohistochemically identified in RA synovial tissue obtained by joint surgery and in the in vitro tissue outgrowth, and confirmed by western blotting and gel shift assays.
RESULTS: Immunohistochemical examination of RA synovial tissue revealed simultaneous expression of various transcription factors (NF-kappa B, c-Jun (a component of AP-1), cAMP responsive element binding protein (CREB), and OCT-1). The same set of transcription factors was expressed in the in vitro tissue outgrowth of RA patients. The early passage RA synovial cells were treated with interleukin 1 beta (IL1 beta) and confirmed translocation of transcription factors into the nucleus by western blotting, and their DNA binding activity by gel shift assays.
CONCLUSION: This study emphasises the importance of the simultaneous expression of several transcription factors for the hyperactivity of RA synovial cells that leads to tissue outgrowth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797555      PMCID: PMC1752716          DOI: 10.1136/ard.57.8.487

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  64 in total

Review 1.  POU-domain transcription factors: pou-er-ful developmental regulators.

Authors:  M G Rosenfeld
Journal:  Genes Dev       Date:  1991-06       Impact factor: 11.361

2.  CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases.

Authors:  M Sheng; M A Thompson; M E Greenberg
Journal:  Science       Date:  1991-06-07       Impact factor: 47.728

Review 3.  Cytokine regulation of metalloproteinase gene expression.

Authors:  A Mauviel
Journal:  J Cell Biochem       Date:  1993-12       Impact factor: 4.429

Review 4.  Transcriptional regulation by CREB and its relatives.

Authors:  K A Lee; N Masson
Journal:  Biochim Biophys Acta       Date:  1993-09-23

Review 5.  Second-line drug therapy for rheumatoid arthritis.

Authors:  J M Cash; J H Klippel
Journal:  N Engl J Med       Date:  1994-05-12       Impact factor: 91.245

Review 6.  Signal transduction and gene regulation: the nuclear response to cAMP.

Authors:  E Lalli; P Sassone-Corsi
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

7.  Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells.

Authors:  M Sakai; K Eguchi; K Terada; M Nakashima; I Yamashita; H Ida; Y Kawabe; T Aoyagi; H Takino; T Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Glucocorticoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanisms.

Authors:  R J Zitnik; N L Whiting; J A Elias
Journal:  Am J Respir Cell Mol Biol       Date:  1994-06       Impact factor: 6.914

9.  Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining.

Authors:  Z Qu; C H Garcia; L M O'Rourke; S R Planck; M Kohli; J T Rosenbaum
Journal:  Arthritis Rheum       Date:  1994-02

10.  Transcription-independent turnover of I kappa B alpha during monocyte adherence: implications for a translational component regulating I kappa B alpha/MAD-3 mRNA levels.

Authors:  A K Lofquist; K Mondal; J S Morris; J S Haskill
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

View more
  6 in total

Review 1.  Role of nuclear factor kappaB in synovial inflammation.

Authors:  Ulf Müller-Ladner; Renate E Gay; Steffen Gay
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

2.  A role for type 1alpha corticotropin-releasing hormone receptors in mediating local changes in chronically inflamed tissue.

Authors:  Jennifer A Ralph; Davide Zocco; Barry Bresnihan; Oliver Fitzgerald; Alice N McEvoy; Evelyn P Murphy
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

3.  Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production.

Authors:  M-C Lu; C-L Yu; H-C Chen; H-C Yu; H-B Huang; N-S Lai
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

4.  Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis.

Authors:  James N Jarvis; Igor Dozmorov; Kaiyu Jiang; Mark Barton Frank; Peter Szodoray; Philip Alex; Michael Centola
Journal:  Arthritis Res Ther       Date:  2003-11-06       Impact factor: 5.156

5.  All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation.

Authors:  Mélanie Kirchmeyer; Meriem Koufany; Sylvie Sebillaud; Patrick Netter; Jean-Yves Jouzeau; Arnaud Bianchi
Journal:  Arthritis Res Ther       Date:  2008-12-10       Impact factor: 5.156

6.  Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes.

Authors:  Corinne Granet; Wova Maslinski; Pierre Miossec
Journal:  Arthritis Res Ther       Date:  2004-02-26       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.